Member Info for RayPointer

RSI in the wrist by any chance?

It just might be a more widespread realisation that Scancell's science is pretty special

You guys are reading a lot into one online presentation of Glymabs in a half-day conference.

Loads of what in the pipeline?

Perhaps you need to do some research.

Good luck!

I'm with you dragon, just judging by Phil's record of postponing news so far.

A cardboard Ferrari to go with the cardboard lab. I like it 😊

Just a little taster for chester 😎

https://www.bing.com/videos/riverview/relatedvideo?q=best+Ferrari+v12+sound&&mid=CC155C7EA761AC2CC900CC155C7EA761AC2CC900&churl=https%3a%2f%2fwww.youtube.com%2fchannel%2fUCJz2fqR0VTdOj74UDFZN8Tg&FORM=VRDGAR

Yes, Marcus

And going it alone will likely make the Immunobody Platform even more valuable.

You can certainly see the attraction of going it alone. If the stage 3 trial looks like it is leading to approval of iSCIB1+, what price then for Immunobody?

Ah, thanks for that, Berm.

I didn't know that.

Yes, and no doubt Eric has made Scancell aware of ctDNA.

But to suggest that this makes Natera a serious contender for an Immunobody or SCIB1 deal is a bit of a stretch.

Sorry, Johnny, very good research, but I will not be going to Fantasy Island 😂

Natera taking out Scancell?

Now that really is fantasy.

Why would a company that specializes in early warning tests for cancer be interested in Scancell?

TF, I would stick with 34. Just think of the publicity if and when the difference reaches 42 which is the ultimate answer.

Temporary name of "34" to reflect the current PFS difference to current SOC.

Shows great confidence that next year the name would automatically change to something greater than "34"

There's got to be a Golden Cross lurking there somewhere.

Where are all the chartists when you need one?

We'll soon find out if there's life on Mars

Hi chester

"Tough times for Phil and his team"

I get the impression that Phil is at his best in the type of situation

It's handy that both Roche and Novartis have their HQ in Basel.

Anyway, it's good that Zak thinks the SP will soon become derisory again.

But hang on, surely Diggle's idea of derisory has been upgraded. 😂

The guy in the black tee-shirt, I just want to know what was in his coffee 😂

Yeah, but those two guys had done zero research on the Immunobody platform and how it works